Niva Bupa Health Insurance amends fair disclosure and leak inquiry policies

Niva Bupa Health Insurance Company Limited has announced amendments to its Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information (UPSI) and its Policy for Inquiry in Case of Leak or Suspected Leak of UPSI. These policies have been consolidated into a single comprehensive document. The updated and consolidated policy was approved by the Board of Directors on November 4, 2026, and will be made available on the company’s website.

Policy Consolidation Approved

Niva Bupa Health Insurance Company Limited has officially consolidated its policies concerning Unpublished Price Sensitive Information (UPSI). The company’s Board of Directors, during a meeting held on Wednesday, November 04, 2026, approved amendments to two key documents: the ‘Code of Practices and Procedures for Fair Disclosure of UPSI’ and the ‘Policy for Inquiry in Case of Leak or Suspected Leak of UPSI’. These have now been integrated into a single, comprehensive policy.

Updated Policy Details

The revised policy aims to streamline operational compliance and regulatory alignment under the SEBI (Prohibition of Insider Trading) Regulations, 2015. It is divided into two parts: Part A addresses the Code of Practices and Procedures for Fair Disclosure of UPSI, and Part B details the Policy for Inquiry in Case of Leak or Suspected Leak of UPSI. The Board’s approval ensures these updated guidelines are in effect from November 04, 2026.

Availability and Next Steps

The updated and consolidated policy is enclosed as Annexure-I and will be published on the company’s official website, www.nivabupa.com. The meeting where these amendments were approved commenced at 02:30 PM (IST) and concluded at 03:10 PM (IST) on the same day. The company has requested stakeholders to take these updates on record.

Source: BSE

Previous Article

SP Capital Financing approves interim dividends and reviews Q2 results

Next Article

Mefcom Capital Markets reports Q2 2026 unaudited financial results